14-04-2008: Cellerix registers the name Ontaril® for its medicine Cx401
Cellerix has registered the name Ontaril® for its medicine Cx401.
19-02-2008: The Lilly Foundation and Cellerix present the book “Cell Therapy”
Cell Therapy is the first book in the world published about a field that is revolutionizing medical practice
6-02-2008: Cellerix appoints Jacques Theurillat as Member of its Board of Directors
Cellerix has appointed Jacques Theurillat as new member of its Board of Directors
25-09-2007: Cellerix grants Axcan rights to Cx401 in North America
Cellerix has entered into an exclusive license and development agreement with Axcan Pharma Inc. for the North American (United States, Canada and Mexico) rights to Cx401.
19-08-2007: Cellerix closes €27,2m financing round to bring product Cx401 to market
Cellerix closes a series B financing round with international venture capital companies and corporate funds from two of the largest pharmaceutical companies.
« Previous 1 2 3 4